Update on TGA information relating to Allergan breast implant recall
AMA members are advised that the Therapeutics Good Administration (TGA) has published Information for health professionals about the Allergan recall.
The information is in relation to Allergan electing to recall their un-implanted macro-textured breast implants and tissue expanders, due to the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in rare cases. Micro-textured and smooth breast implants are not affected by this hazard alert and sponsor initiated recall.
The update brings together a range of resources and information, including references to patient implant cards, registering with the Australian Breast Device Registry and recently published material on managing asymptomatic patients.
Information for GPs is available here.